INS | Insulin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48/1693_B_2_7_rna_selected_60x60.jpg) | Tissue enriched |
INSR | Insulin receptor | CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| ![](/images/36302/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/36302/112004_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
IRS1 | Insulin receptor substrate 1 | Disease related genes Plasma proteins
| ![](/images/5261/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/5261/19657_B_9_1_rna_selected_60x60.jpg) | Mixed |
IRS2 | Insulin receptor substrate 2 | Cancer-related genes Plasma proteins
| ![](/images/16944/ihc_selected_60x60.jpg) | ![](/images/54664/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16944/36405_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
IGF1R | Insulin-like growth factor 1 receptor | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| ![](/images/45563/ihc_selected_60x60.jpg) | ![](/images/10268/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/10268/32661_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
IGF1 | Insulin-like growth factor 1 (somatomedin C) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| ![](/images/48946/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48946/110991_B_5_3_rna_selected_60x60.jpg) | Mixed |
IGFBP3 | Insulin-like growth factor binding protein 3 | Cancer-related genes Plasma proteins Predicted secreted proteins
| ![](/images/10360/ihc_selected_60x60.jpg) | ![](/images/10360/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/10360/35657_A_6_6_rna_selected_60x60.jpg) | Tissue enhanced |
IDE | Insulin-degrading enzyme | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| ![](/images/63478/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/63478/143062_B_7_6_rna_selected_60x60.jpg) | Expressed in all |
IGF2 | Insulin-like growth factor 2 (somatomedin A) | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images/24999/ihc_selected_60x60.jpg) | ![](/images/24999/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/24999/56537_A_2_5_rna_selected_60x60.jpg) | Tissue enriched |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | ![](/images/1216/if_selected_60x60.jpg) | | ![](/images/4268/19233_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
GRB10 | Growth factor receptor-bound protein 10 | Cancer-related genes
| ![](/images/19423/ihc_selected_60x60.jpg) | ![](/images/31818/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/19423/43437_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
INSRR | Insulin receptor-related receptor | Enzymes Predicted membrane proteins
| ![](/images/25285/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25285/56886_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
PTPN1 | Protein tyrosine phosphatase, non-receptor type 1 | Enzymes Predicted membrane proteins
| | | | ![](/images/15217/36055_B_3_4_rna_selected_60x60.jpg) | Expressed in all |
SORBS1 | Sorbin and SH3 domain containing 1 | | | | ![](/images_static/rna_center.gif) | ![](/images/27559/58594_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| ![](/images/42318/ihc_selected_60x60.jpg) | ![](/images/42318/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/11451/26291_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
IGF2R | Insulin-like growth factor 2 receptor | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | ![](/images/11332/ihc_cell_selected_60x60.jpg) | ![](/images/11332/29187_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
IRS4 | Insulin receptor substrate 4 | Predicted secreted proteins
| ![](/images/17372/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17372/109494_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
PRKCZ | Protein kinase C, zeta | Enzymes Plasma proteins
| | ![](/images/21851/if_selected_60x60.jpg) | | ![](/images/21851/49689_B_9_3_rna_selected_60x60.jpg) | Mixed |
PTPN11 | Protein tyrosine phosphatase, non-receptor type 11 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | ![](/images/5377/if_selected_60x60.jpg) | ![](/images/5377/ihc_cell_selected_60x60.jpg) | ![](/images/5377/18256_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
PDX1 | Pancreatic and duodenal homeobox 1 | Disease related genes Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25873/54798_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
PHIP | Pleckstrin homology domain interacting protein | | ![](/images/19838/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/19838/117803_A_3_4_rna_selected_60x60.jpg) | Expressed in all |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/16544/ihc_cell_selected_60x60.jpg) | ![](/images/16544/35881_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/32904/78602_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
GCK | Glucokinase (hexokinase 4) | Disease related genes Enzymes Potential drug targets
| ![](/images/7034/ihc_selected_60x60.jpg) | ![](/images/7093/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7034/21178_B_9_1_rna_selected_60x60.jpg) | Mixed |
GIP | Gastric inhibitory polypeptide | Plasma proteins Predicted secreted proteins
| | ![](/images/21612/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21612/140668_B_8_3_rna_selected_60x60.jpg) | Group enriched |
GPLD1 | Glycosylphosphatidylinositol specific phospholipase D1 | Enzymes Plasma proteins Predicted secreted proteins
| ![](/images/12500/ihc_selected_60x60.jpg) | ![](/images/12500/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/12500/29572_A_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
IGFBP1 | Insulin-like growth factor binding protein 1 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46972/146495_B_7_7_rna_selected_60x60.jpg) | Group enriched |
IGFBP4 | Insulin-like growth factor binding protein 4 | Plasma proteins Predicted secreted proteins
| ![](/images/66240/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/66240/148050_B_7_4_rna_selected_60x60.jpg) | Expressed in all |
ISL1 | ISL LIM homeobox 1 | Transcription factors
| ![](/images/57416/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/57416/132767_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
KCNJ11 | Potassium inwardly-rectifying channel, subfamily J, member 11 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/48891/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48891/121832_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
LEP | Leptin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images/30721/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/10490/ihc_cell_selected_60x60.jpg) | ![](/images/10490/32979_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
SREBF1 | Sterol regulatory element binding transcription factor 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins Transcription factors
| ![](/images/43343/ihc_selected_60x60.jpg) | ![](/images/5406/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/43343/132103_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
IGFBP5 | Insulin-like growth factor binding protein 5 | Plasma proteins Predicted secreted proteins
| ![](/images/9216/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9216/27280_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
INPPL1 | Inositol polyphosphate phosphatase-like 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| ![](/images/37601/ihc_selected_60x60.jpg) | | ![](/images/37601/ihc_cell_selected_60x60.jpg) | ![](/images/37601/84504_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
INSIG2 | Insulin induced gene 2 | Predicted membrane proteins
| ![](/images/33861/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33861/78001_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
INSL3 | Insulin-like 3 (Leydig cell) | Disease related genes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28615/59748_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
AKT2 | V-akt murine thymoma viral oncogene homolog 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images/4204/ihc_cell_selected_60x60.jpg) | ![](/images/4204/11545_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
BAIAP2 | BAI1-associated protein 2 | Plasma proteins
| | | | ![](/images/27421/57220_B_2_7_rna_selected_60x60.jpg) | Expressed in all |
C2CD5 | C2 calcium-dependent domain containing 5 | | ![](/images/46194/ihc_selected_60x60.jpg) | | ![](/images/46194/ihc_cell_selected_60x60.jpg) | ![](/images/46194/104723_B_9_8_rna_selected_60x60.jpg) | Expressed in all |
CIDEC | Cell death-inducing DFFA-like effector c | Disease related genes
| ![](/images/20553/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18837/42540_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
GCG | Glucagon | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/40/ihc_cell_selected_60x60.jpg) | ![](/images/40/343_B_7_3_rna_selected_60x60.jpg) | Tissue enriched |
GHRL | Ghrelin/obestatin prepropeptide | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14246/143314_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
GIPR | Gastric inhibitory polypeptide receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images/22710/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22710/112109_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
GSK3A | Glycogen synthase kinase 3 alpha | Cancer-related genes Enzymes
| ![](/images/4422/ihc_selected_60x60.jpg) | | ![](/images/28423/ihc_cell_selected_60x60.jpg) | ![](/images/4422/12765_A_1_5_rna_selected_60x60.jpg) | Expressed in all |
INPP5K | Inositol polyphosphate-5-phosphatase K | Enzymes
| ![](/images/31044/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31044/71124_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
INSL5 | Insulin-like 5 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30100/140637_B_1_8_rna_selected_60x60.jpg) | Group enriched |
INSL6 | Insulin-like 6 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/21364/ihc_cell_selected_60x60.jpg) | ![](/images/21364/50592_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21516/109609_B_7_2_rna_selected_60x60.jpg) | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3278/10188_B_8_5_rna_selected_60x60.jpg) | Group enriched |
PDE3B | Phosphodiesterase 3B, cGMP-inhibited | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9497/31482_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |